Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-23-000335
Filing Date
2023-01-13
Accepted
2023-01-13 16:19:44
Documents
1
Period of Report
2022-12-23

Document Format Files

Seq Description Document Type Size
1 RXRX - CHANGES IN BENEFICIAL OWNERSHIP rxrx-form4_011123.html 4  
1 RXRX - CHANGES IN BENEFICIAL OWNERSHIP rxrx-form4_011123.xml 4 28440
  Complete submission text file 0001387131-23-000335.txt   30749
Mailing Address P. O. BOX 45005 ABU DHABI C0 UAE
Business Address P. O. BOX 45005 ABU DHABI C0 UAE 971.2.616.0099
Mamoura Diversified Global Holding PJSC (Reporting) CIK: 0001419351 (see all company filings)

State of Incorp.: C0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 23529003

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 45005 ABU DHABI C0 00000
Business Address P.O. BOX 45005 ABU DHABI C0 00000 971-2413-0000
Mubadala Investment Co PJSC (Reporting) CIK: 0001704268 (see all company filings)

State of Incorp.: C0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 23529004